[go: up one dir, main page]

DK261384D0 - Renset hematoporphyrinderivat til diagnose og behandling af tumorer - Google Patents

Renset hematoporphyrinderivat til diagnose og behandling af tumorer

Info

Publication number
DK261384D0
DK261384D0 DK2613/84A DK261384A DK261384D0 DK 261384 D0 DK261384 D0 DK 261384D0 DK 2613/84 A DK2613/84 A DK 2613/84A DK 261384 A DK261384 A DK 261384A DK 261384 D0 DK261384 D0 DK 261384D0
Authority
DK
Denmark
Prior art keywords
tumors
molecular weight
diagnosis
treatment
substance
Prior art date
Application number
DK2613/84A
Other languages
English (en)
Other versions
DK172284B1 (da
DK261384A (da
Inventor
Kenneth R Weishaupt
Thomas J Dougherty
William R Potter
Original Assignee
Oncology Research & Dev Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncology Research & Dev Inc filed Critical Oncology Research & Dev Inc
Publication of DK261384D0 publication Critical patent/DK261384D0/da
Publication of DK261384A publication Critical patent/DK261384A/da
Application granted granted Critical
Publication of DK172284B1 publication Critical patent/DK172284B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A61B5/0075—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by spectroscopy, i.e. measuring spectra, e.g. Raman spectroscopy, infrared absorption spectroscopy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A61B5/0082—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes
    • A61B5/0084—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes for introduction into the body, e.g. by catheters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0601—Apparatus for use inside the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/062—Photodynamic therapy, i.e. excitation of an agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK261384A 1982-09-27 1984-05-25 Renset hematoporfyrinderivat til diagnose og behandling af tumorer samt fremgangsmåde til fremstilling af de rensede derivater og præparater indeholdende dem DK172284B1 (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US42464782A 1982-09-27 1982-09-27
US42464782 1982-09-27
US48134583A 1983-04-01 1983-04-01
US48134583 1983-04-01
PCT/US1983/001379 WO1984001382A1 (en) 1982-09-27 1983-09-09 Purified hematoporphyrin derivative for diagnosis and treatment of tumors, and method
US8301379 1983-09-09

Publications (3)

Publication Number Publication Date
DK261384D0 true DK261384D0 (da) 1984-05-25
DK261384A DK261384A (da) 1984-05-25
DK172284B1 DK172284B1 (da) 1998-02-23

Family

ID=27026406

Family Applications (1)

Application Number Title Priority Date Filing Date
DK261384A DK172284B1 (da) 1982-09-27 1984-05-25 Renset hematoporfyrinderivat til diagnose og behandling af tumorer samt fremgangsmåde til fremstilling af de rensede derivater og præparater indeholdende dem

Country Status (10)

Country Link
EP (1) EP0120054B1 (da)
JP (1) JPS60500132A (da)
AT (1) ATE53204T1 (da)
AU (1) AU581840B2 (da)
CA (1) CA1271746A (da)
DE (1) DE3381616D1 (da)
DK (1) DK172284B1 (da)
NL (1) NL940021I2 (da)
NO (1) NO166284C (da)
WO (1) WO1984001382A1 (da)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4649151A (en) * 1982-09-27 1987-03-10 Health Research, Inc. Drugs comprising porphyrins
US4675338A (en) * 1984-07-18 1987-06-23 Nippon Petrochemicals Co., Ltd. Tetrapyrrole therapeutic agents
US4693885A (en) * 1984-07-18 1987-09-15 Nippon Petrochemicals Co., Ltd. Tetrapyrrole therapeutic agents
US5104637A (en) * 1985-02-06 1992-04-14 University Of Cincinnati Radio labeled dihematophorphyrin ether and its use in detecting and treating neoplastic tissue
US5066274A (en) * 1985-04-30 1991-11-19 Nippon Petrochemicals Company, Ltd. Tetrapyrrole therapeutic agents
US4977177A (en) * 1985-04-30 1990-12-11 Nippon Petrochemicals Company, Ltd. Tetrapyrrole polyaminomonocarboxylic acid therapeutic agents
AU589957B2 (en) * 1985-04-30 1989-10-26 Nippon Petrochemicals Company Limited New tetrapyrrole therapeutic agents
US4656186A (en) 1985-04-30 1987-04-07 Nippon Petrochemicals Co., Ltd. Tetrapyrrole therapeutic agents
GB8522670D0 (en) * 1985-09-13 1985-10-16 Efamol Ltd Drug treatments
EP0220686B1 (en) * 1985-10-23 1992-12-30 Nihon Medi-Physics Co., Ltd. Porphyrin derivatives, and their production and use
US5051415A (en) * 1986-01-02 1991-09-24 The University Of Toledo Production and use of purpurins, chlorins and purpurin- and chlorin-containing compositions
US5534506A (en) * 1986-01-02 1996-07-09 University Of Toledo Use of purpurins, chlorins and purpurin- and chlorin-containing compositions
EP0256036B1 (en) * 1986-01-02 1993-04-07 The University Of Toledo Production and use of purpurins, chlorins and purpurin- and chlorin-containing compositions
US5216012A (en) * 1986-01-02 1993-06-01 University Of Toledo Production and use of purpurins, chlorins and purpurin- and chlorin-containing compositions
US4882234A (en) * 1986-11-12 1989-11-21 Healux, Inc. Storage-stable porphin compositions and a method for their manufacture
US4920143A (en) * 1987-04-23 1990-04-24 University Of British Columbia Hydro-monobenzoporphyrin wavelength-specific cytotoxic agents
US5283255A (en) * 1987-01-20 1994-02-01 The University Of British Columbia Wavelength-specific cytotoxic agents
US5171749A (en) * 1987-01-20 1992-12-15 University Of British Columbia Wavelength-specific cytotoxic agents
US4925736A (en) * 1988-07-06 1990-05-15 Long Island Jewish Medical Center Topical hematoporphyrin
USRE38994E1 (en) 1988-07-20 2006-02-28 Health Research, Inc. Pyropheophorbides conjugates and their use in photodynamic therapy
USRE39094E1 (en) 1988-07-20 2006-05-09 Health Research, Inc. Pyropheophorbides and their use in photodynamic therapy
GB2254417A (en) * 1991-04-05 1992-10-07 Bijan Jouza Photodynamic laser detection for cancer diagnosis
NL9200143A (nl) * 1992-01-27 1993-08-16 Seehof Lab F & E Ges Werkwijze voor de bereiding van een actief middel te gebruiken voor de fotodynamische therapie en voor het vaststellen van een diagnose, therapeutisch middel en diagnosticum dat het actief middel bevat en farmaceutische samenstelling.
US5948061A (en) 1996-10-29 1999-09-07 Double Click, Inc. Method of delivery, targeting, and measuring advertising over networks
US7039599B2 (en) 1997-06-16 2006-05-02 Doubleclick Inc. Method and apparatus for automatic placement of advertising
EP1142260A2 (en) 1998-08-03 2001-10-10 Doubleclick Inc. Network for distribution of re-targeted advertising
US7897140B2 (en) 1999-12-23 2011-03-01 Health Research, Inc. Multi DTPA conjugated tetrapyrollic compounds for phototherapeutic contrast agents
US6624187B1 (en) 2000-06-12 2003-09-23 Health Research, Inc. Long wave length absorbing bacteriochlorin alkyl ether analogs
AU2003248747A1 (en) 2002-06-27 2004-01-19 Health Research, Inc. Fluorinated chlorin and bacteriochlorin photosensitizers for photodynamic therapy
EP2036908A3 (en) 2002-07-02 2009-05-13 Health Research, INC. Efficient synthesis of pyropheophorbide a derivates

Also Published As

Publication number Publication date
JPS60500132A (ja) 1985-01-31
AU581840B2 (en) 1989-03-09
ATE53204T1 (de) 1990-06-15
DE3381616D1 (de) 1990-07-05
EP0120054A1 (en) 1984-10-03
DK172284B1 (da) 1998-02-23
NO166284B (no) 1991-03-18
NO842089L (no) 1984-05-25
NL940021I1 (nl) 1997-03-03
NO166284C (no) 1991-06-26
WO1984001382A1 (en) 1984-04-12
CA1271746A (en) 1990-07-17
EP0120054A4 (en) 1985-04-11
EP0120054B1 (en) 1990-05-30
NL940021I2 (nl) 1997-05-01
AU2032283A (en) 1984-04-24
DK261384A (da) 1984-05-25

Similar Documents

Publication Publication Date Title
DK261384D0 (da) Renset hematoporphyrinderivat til diagnose og behandling af tumorer
Schilling et al. Isolation, Structure and Synthesis of a Lathyrus Factor From L. Odoratus1, 2
ATE108763T1 (de) Neue benzocyclohepten-derivate, deren herstellung und verwendung für pharmazeutika.
ATE27273T1 (de) Verfahren zur herstellung von optisch aktiven carbazol-derivaten, neue r- und s-carbazolderivate, sowie arzneimittel, die diese verbindungen enthalten.
DE3775882D1 (de) Substituierte 6-fluor-4-oxo-1,4-dihydrochinolin-3-carbonsaeuren ; deren derivate; diese verbindung enthaltende pharmazeutische zubereitungen und verfahren zur herstellung dieser verbindungen.
ATE25246T1 (de) Triphenylimidazolyloxyalkansaeuren und ihre derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
ATE1192T1 (de) Verfahren zur herstellung von beta-lactam-derivaten, die so erhaltenen neuen derivate sowie diese derivate enthaltende pharmazeutische zusammensetzungen.
US4128542A (en) Peptide derivatives
DE2808111A1 (de) Neue dipeptidderivate und deren verwendung zur messung der enzymatischen aktivitaet
GB2053232A (en) Dipeptides their preparation and the medicaments in which they are present
Slocum et al. The preparation of several N-Substituted and N, N-Disubstituted ferrocenesulfonamides
ES2132872T3 (es) Procedimiento de purificacion de diacetilreina.
Wolf et al. Amides and amino acid derivatives of biotin
JPS58203982A (ja) ビタミンｅ−アミノ酸エステル類およびその製造方法
GB2098989A (en) Lysine salts
ES2037003T3 (es) Procedimiento para preparar peptidos empleando percloratos.
DE2730524A1 (de) Peptidderivate und deren herstellung
DE2416355A1 (de) Direkte synthese von dopaminaminosaeureamiden
Ohashi et al. Constitutional Amino Acids of the Antibiotic YA–56
JPS5795918A (en) Purification of immunoglobulin
Höfer et al. Desamino Analogs of Thyroxine1
DE2721761A1 (de) Peptidderivate und verfahren zu deren herstellung
EP0280868A3 (en) Imidazo- and triazolothiadiazines, process for their preparation, medicaments containing them and their use as well as some of the intermediates obtained during the preparation of said compounds
SU568632A1 (ru) Способ выделени транс-6,14-дигидролевопимаровой-6,14-эндо-21-эндо-пропановой кислоты
SU810689A1 (ru) Способ получени карбимидов 3-фе-НАцилидЕНХиНОКСАлОНОВ-2

Legal Events

Date Code Title Description
PUP Patent expired
CTFF Application for supplementary protection certificate (spc) filed

Spc suppl protection certif: CA 2000 00012

Filing date: 20000517

Expiry date: 20080909